Carrera-Hueso, F. J. http://orcid.org/0000-0002-4459-6059
Álvarez-Arroyo, L. http://orcid.org/0000-0002-3745-4263
Poquet-Jornet, J. E. http://orcid.org/0000-0002-3114-2795
Vázquez-Ferreiro, P. http://orcid.org/0000-0001-8367-3996
Martínez-Gonzalbez, R. http://orcid.org/0000-0001-6430-7624
El-Qutob, D. http://orcid.org/0000-0003-4837-782X
Ramón-Barrios, M. A. http://orcid.org/0000-0003-2787-427X
Martínez-Martínez, F.
Poveda-Andrés, J. L.
Crespo-Palomo, C.
Article History
Received: 13 June 2021
Accepted: 29 September 2021
First Online: 3 November 2021
Declarations
:
: The study was registered with the Spanish Agency of Medicines and Medical Products (AEMPS) and approved by the hospital’s ethics committee.Verbal informed consent was obtained from all patients and noted in the patients’ medical records. This procedure was authorized by the Spanish Health authorities in view of the exceptional epidemiological situation.
: The work described has not been published previously, is not under consideration for publication elsewhere and, if accepted, will not be published elsewhere without the written consent of the copyright-holder. Its publication is approved by all authors and tacitly or explicitly by the responsible authorities.
: Dr. Crespo received grant or personal fees outside the submitted work from Novartis, Pfizer, Abbvie, Gebro, Takeda, Shire, Mundipharma, Almirall, Boston Scientific, Dexcom, Hospital Clinic of Barcelona and GlaxoSmithKline.The other authors declare that they have not conflict of interest.